06 Apr 2009 06:00 AM
Zosano Pharma, Inc. Presents Positive Phase 2 Results Of Its Needle-Free Osteoporosis Therapy
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, today presented positive results from its phase 2 study of the ZP-PTH rapid delivery patch for the treatment of osteoporosis at the 8th International Symposium on Osteoporosis in Washington, D.C. The study was a randomized, multi-center, double-blind, multi-dose trial designed to determine safety and efficacy of the ZP-PTH rapid delivery patch for the treatment of osteoporosis…
